Today: 20 May 2026
Blackbaud (BLKB) stock sinks 6% to start 2026 as software sector slides — what’s next
4 January 2026
2 mins read

Blackbaud (BLKB) stock sinks 6% to start 2026 as software sector slides — what’s next

NEW YORK, January 3, 2026, 21:05 ET — Market closed

  • Blackbaud shares closed down 6% on Friday, underperforming a broader software basket.
  • The pullback came as Wall Street’s first 2026 session stayed choppy despite gains in the Dow and S&P 500.
  • Focus now shifts to next week’s U.S. jobs and inflation data, plus Blackbaud’s next earnings window.

Blackbaud (BLKB) shares ended Friday down about 6% at $59.52, after opening at $63.21 and sliding as low as $59.32 as trading got underway for 2026. Volume was about 377,000 shares.

The drop outpaced the iShares Expanded Tech-Software Sector ETF — an exchange-traded fund that tracks a basket of U.S. software stocks — which fell about 2.9% in the same session.

The broader tape was mixed. The Dow and S&P 500 finished higher while the Nasdaq was essentially flat, with chipmakers lifting the market even as several heavyweight tech names fell, a Reuters market wrap showed. Charles Schwab’s head of trading and derivatives strategy Joe Mazzola described the mood as “buy the dip, sell the rip,” adding that investors have become more conscious of the valuations they are paying for some AI-linked trades. Reuters

Blackbaud sells cloud software used by nonprofits, schools and other organizations that manage fundraising, finance and related operations, the company says.

That business model can leave the stock sensitive to shifts in interest-rate expectations, because investors tend to discount future cash flows more heavily when rates stay higher for longer.

With the market closed for the weekend, the next near-term swing factor is macro. Investors are gearing up for next week’s U.S. labor-market report (due January 9) and consumer-price data (due January 13), Reuters’ “Week Ahead” column reported. The same report said fed funds futures — interest-rate contracts that reflect where traders expect the Fed’s policy rate to go — imply little chance of a cut at the late-January meeting and roughly even odds of a quarter-point cut in March. Reuters

Technically, BLKB is trading closer to its lows than its highs. The stock’s 52-week range spans $54.56 to $81.39, leaving Friday’s close within about $5 of the low.

In extended trading — the electronic session outside regular market hours — Blackbaud was little changed from the close, according to MarketBeat pricing. MarketBeat also lists Blackbaud’s next earnings date as an estimate around February 17, noting the company has not confirmed a publication date.

Before Monday’s open, traders will be watching whether software shares continue to lag after Friday’s slide, or whether the group stabilizes as liquidity returns after the holiday period.

Next week’s data slate has the potential to reset the market’s rate narrative quickly. A hotter inflation print or a stronger jobs report can push yields higher and pressure rate-sensitive growth shares, while softer readings tend to do the opposite.

Earnings season is also set to ramp up mid-month, which can shift sentiment across equity sectors even when a company has no immediate news of its own.

For Blackbaud specifically, investors will be looking for signs that demand in nonprofit and education end-markets is holding up, and for any commentary on customer retention, product uptake and operating efficiency when the company next reports.

After one trading day in 2026, BLKB is already down about 6% year to date. The next test is whether the stock can hold above its recent lows as macro headlines return to the driver’s seat.

Stock Market Today

  • Euronext Q1 2026 Sees Record Trading Volumes and 15.3% Revenue Growth
    May 20, 2026, 5:43 AM EDT. Euronext reported a record Q1 2026 with cash equity trading and clearing revenue up 30.8% to €123 million, driven by high market volatility and the full contribution from Euronext Athens. Total underlying revenue rose 15.3% to €528.5 million, marking the exchange's eighth consecutive quarter of double-digit growth. Average daily cash equity transaction value in April reached €16.4 billion, with a 64.1% market share. Commodities trading revenue climbed 13.9%, while FX revenue grew 5.8%. ETF trading surged 84% since September 2025, boosted by the launch of mini ETF options. Adjusted EBITDA rose 16.7% to €343.2 million, with net income up 17.7%. Euronext declared a €3.18 dividend per share, reflecting a 50% payout, payable in May.

Latest articles

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Wall Street Puts $150 Target on Intel in AI Push

Wall Street Puts $150 Target on Intel in AI Push

20 May 2026
Intel shares rose 2.43% to $110.80 on Tuesday, ending a five-day losing streak. The stock rebounded as analysts raised price targets, citing demand for AI server CPUs. Intel traded between $102.40 and $113.07 during the session. The Nasdaq Composite fell 0.84%, with Nvidia and AMD also down.
Marvell moves as earnings nears, eyes on AI chips

Marvell moves as earnings nears, eyes on AI chips

20 May 2026
Marvell Technology shares rose 4.53% to $184.25 in premarket trading Wednesday, extending Tuesday’s 4.35% gain. The company will report fiscal Q1 2027 results after the close on May 27. Analysts at Evercore ISI, Melius Research, and CLSA raised price targets, citing strong demand for custom AI chips. Marvell posted record fiscal 2026 revenue of $8.195 billion in March.
Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus
Previous Story

Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

Baidu stock today: BIDU jumps on Kunlunxin Hong Kong IPO plan as AI-chip frenzy builds
Next Story

Baidu stock today: BIDU jumps on Kunlunxin Hong Kong IPO plan as AI-chip frenzy builds

Go toTop